Paper21079779
Versican G3 promotes mouse mammary tumor cell growth, migration, and metastasis by influencing EGF receptor signaling.
Du WW and 8 others. PLoS One, 2010. Cited by 58 papers, by iCite.
Cite this record
ConductScience Library. Versican G3 promotes mouse mammary tumor cell growth, migration, and metastasis by influencing EGF receptor signaling. Papers, record 21079779. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21079779
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Versican G3 promotes mouse mammary tumor cell growth, migration, and metastasis by influencing EGF receptor signaling.
- PubMed
Topics25
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Movement | Major topic |
| Cell Proliferation | Major topic |
| ErbB Receptors | Major topic |
| Mammary Neoplasms, Experimental | Major topic |
| Signal Transduction | Major topic |
| Versicans | Major topic |
| Animals | |
| Binding Sites | |
| Blotting, Western | |
| Cell Line, Tumor | |
| Cyclin-Dependent Kinase 2 | |
| Epidermal Growth Factor | |
| Female | |
| Gene Expression Regulation, Neoplastic | |
| Glycogen Synthase Kinase 3 | |
| Glycogen Synthase Kinase 3 beta | |
| Humans | |
| Mice | |
| Mice, Inbred BALB C | |
| Neoplasm Metastasis | |
| Neoplasm Transplantation | |
| Phosphorylation | |
| Reverse Transcriptase Polymerase Chain Reaction | |
| Serine | |
| Transfection |
Source PubMed
References64
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11297534 | Identification of the motif in versican G3 domain that plays a dominant-negative effect on astrocytoma cell proliferation through inhibiting versican secretion and binding. | J Biol Chem | 2001 | https://conductscience.org/library/papers/11297534 | PubMed |
| 2 | 9989833 | Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors. | Oncogene | 1999 | https://conductscience.org/library/papers/9989833 | PubMed |
| 3 | 10411109 | A novel orthotopic model of breast cancer metastasis to bone. | Clin Exp Metastasis | 1999 | https://conductscience.org/library/papers/10411109 | PubMed |
| 4 | 8925983 | [Changes in the cell cycle in breast cancer]. | Ginecol Obstet Mex | 1996 | https://conductscience.org/library/papers/8925983 | PubMed |
| 5 | 14766798 | Versican/PG-M G3 domain promotes tumor growth and angiogenesis. | FASEB J | 2004 | https://conductscience.org/library/papers/14766798 | PubMed |
| 6 | 10978313 | The p38 pathway provides negative feedback for Ras proliferative signaling. | J Biol Chem | 2000 | https://conductscience.org/library/papers/10978313 | PubMed |
| 7 | 18077375 | MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression. | Proc Natl Acad Sci U S A | 2007 | https://conductscience.org/library/papers/18077375 | PubMed |
| 8 | 11726670 | Versican interacts with fibrillin-1 and links extracellular microfibrils to other connective tissue networks. | J Biol Chem | 2002 | https://conductscience.org/library/papers/11726670 | PubMed |
| 9 | 2857419 | Epidermal-growth-factor receptors and oestrogen receptors in human breast cancer. | Lancet | 1985 | https://conductscience.org/library/papers/2857419 | PubMed |
| 10 | 18682844 | HER2 oncogenic function escapes EGFR tyrosine kinase inhibitors via activation of alternative HER receptors in breast cancer cells. | PLoS One | 2008 | https://conductscience.org/library/papers/18682844 | PubMed |
| 11 | 8627343 | Differential expression of versican isoforms in brain tumors. | J Neuropathol Exp Neurol | 1996 | https://conductscience.org/library/papers/8627343 | PubMed |
| 12 | 2583089 | Multiple domains of the large fibroblast proteoglycan, versican. | EMBO J | 1989 | https://conductscience.org/library/papers/2583089 | PubMed |
| 13 | 8034670 | Link protein is ubiquitously expressed in non-cartilaginous tissues where it enhances and stabilizes the interaction of proteoglycans with hyaluronic acid. | J Biol Chem | 1994 | https://conductscience.org/library/papers/8034670 | PubMed |
| 14 | 16842147 | Recent advances in the research and development of RAF kinase inhibitors. | Curr Top Med Chem | 2006 | https://conductscience.org/library/papers/16842147 | PubMed |
| 15 | 19844573 | MicroRNA miR-378 regulates nephronectin expression modulating osteoblast differentiation by targeting GalNT-7. | PLoS One | 2009 | https://conductscience.org/library/papers/19844573 | PubMed |
| 16 | 2885917 | erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. | Science | 1987 | https://conductscience.org/library/papers/2885917 | PubMed |
| 17 | 20544025 | An antimicrobial peptide regulates tumor-associated macrophage trafficking via the chemokine receptor CCR2, a model for tumorigenesis. | PLoS One | 2010 | https://conductscience.org/library/papers/20544025 | PubMed |
| 18 | 16045811 | The interaction of versican with its binding partners. | Cell Res | 2005 | https://conductscience.org/library/papers/16045811 | PubMed |
| 19 | 10801813 | Tandem repeats are involved in G1 domain inhibition of versican expression and secretion and the G3 domain enhances glycosaminoglycan modification and product secretion via the complement-binding protein-like motif. | J Biol Chem | 2000 | https://conductscience.org/library/papers/10801813 | PubMed |
| 20 | 10400671 | Fibulin-1 is a ligand for the C-type lectin domains of aggrecan and versican. | J Biol Chem | 1999 | https://conductscience.org/library/papers/10400671 | PubMed |
Cited by40
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 58 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41463344 | Proteoglycans in Breast Cancer: Friends and Foes. | Biomolecules | 2025 | https://conductscience.org/library/papers/41463344 | PubMed |
| 39812750 | Pan-cancer secreted proteome and skeletal muscle regulation: insight from a proteogenomic data-driven knowledge base. | Funct Integr Genomics | 2025 | https://conductscience.org/library/papers/39812750 | PubMed |
| 37942010 | Cancer-specific glycosylation of CD13 impacts its detection and activity in preclinical cancer tissues. | iScience | 2023 | https://conductscience.org/library/papers/37942010 | PubMed |
| 37175152 | Targeting Chondroitin Sulphate Synthase 1 (Chsy1) Promotes Axon Growth Following Neurorrhaphy by Suppressing Versican Accumulation. | Molecules | 2023 | https://conductscience.org/library/papers/37175152 | PubMed |
| 35024241 | Promotion of tumor progression by exosome transmission of circular RNA circSKA3. | Mol Ther Nucleic Acids | 2022 | https://conductscience.org/library/papers/35024241 | PubMed |
| 34409033 | Neural Tissue Homeostasis and Repair Is Regulated via CS and DS Proteoglycan Motifs. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/34409033 | PubMed |
| 33750326 | Comprehensive analysis of ceRNA networks reveals prognostic lncRNAs related to immune infiltration in colorectal cancer. | BMC Cancer | 2021 | https://conductscience.org/library/papers/33750326 | PubMed |
| 33264413 | Manganese Porphyrin and Radiotherapy Improves Local Tumor Response and Overall Survival in Orthotopic Murine Mammary Carcinoma Models. | Radiat Res | 2021 | https://conductscience.org/library/papers/33264413 | PubMed |
| 33163489 | Three-Dimensional Models as a New Frontier for Studying the Role of Proteoglycans in the Normal and Malignant Breast Microenvironment. | Front Cell Dev Biol | 2020 | https://conductscience.org/library/papers/33163489 | PubMed |
| 33131383 | Versican: A Dynamic Regulator of the Extracellular Matrix. | J Histochem Cytochem | 2020 | https://conductscience.org/library/papers/33131383 | PubMed |
| 32623942 | Versican and Versican-matrikines in Cancer Progression, Inflammation, and Immunity. | J Histochem Cytochem | 2020 | https://conductscience.org/library/papers/32623942 | PubMed |
| 32296047 | Molecular principles of metastasis: a hallmark of cancer revisited. | Signal Transduct Target Ther | 2020 | https://conductscience.org/library/papers/32296047 | PubMed |
| 31605014 | VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR-PI3K-AKT pathway. | Oncogene | 2020 | https://conductscience.org/library/papers/31605014 | PubMed |
| 31157165 | Protein Glycosylation and Tumor Microenvironment Alterations Driving Cancer Hallmarks. | Front Oncol | 2019 | https://conductscience.org/library/papers/31157165 | PubMed |
| 30974514 | Dissecting the role of hyaluronan synthases in the tumor microenvironment. | FEBS J | 2019 | https://conductscience.org/library/papers/30974514 | PubMed |
| 29765250 | Genetic variants in the exon region of versican predict survival of patients with resected early-stage hepatitis B virus-associated hepatocellular carcinoma. | Cancer Manag Res | 2018 | https://conductscience.org/library/papers/29765250 | PubMed |
| 29559954 | Proteoglycans-Biomarkers and Targets in Cancer Therapy. | Front Endocrinol (Lausanne) | 2018 | https://conductscience.org/library/papers/29559954 | PubMed |
| 28684419 | Versican G1 domain enhances adenoviral-mediated transgene expression and can be modulated by inhibitors of the Janus kinase (JAK)/STAT and Src family kinase pathways. | J Biol Chem | 2017 | https://conductscience.org/library/papers/28684419 | PubMed |
| 28323982 | Versican Proteolysis by ADAMTS Proteases and Its Influence on Sex Steroid Receptor Expression in Uterine Leiomyoma. | J Clin Endocrinol Metab | 2017 | https://conductscience.org/library/papers/28323982 | PubMed |
| 26873137 | Versican and vascular endothelial growth factor expression levels in peritoneal metastases from colorectal cancer are associated with survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. | Clin Exp Metastasis | 2016 | https://conductscience.org/library/papers/26873137 | PubMed |
Genes13
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21079779
GET https://conductscience.org/api/papers/v1/21079779/references?page=2